Iron overload in myelodysplastic syndromes (MDS) – diagnosis, management, and response criteria: a proposal of the Austrian MDS platform

por Valent, P, Krieger, O, Stauder, R, Wimazal, F, Nösslinger, T, Sperr, W R, Sill, H, Bettelheim, P, Pfeilstöcker, M
Publicado 2008

BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils

por Smiljkovic, D., Blatt, K., Stefanzl, G., Dorofeeva, Y., Skrabs, C., Focke‐Tejkl, M., Sperr, W. R., Jaeger, U., Valenta, R., Valent, P.
Publicado 2017

Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis

por Rabitsch, W., Bojic, M., Wohlfarth, P., Leiner, M., Schörgenhofer, C., Kalhs, P., Schulenburg, A., Sillaber, C., Mitterbauer, M., Sperr, W. R., Jäger, U., Skrabs, K., Greinix, H., Hermann, A., Lamm, W.
Publicado 2016

Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia

por Heller, G, Topakian, T, Altenberger, C, Cerny-Reiterer, S, Herndlhofer, S, Ziegler, B, Datlinger, P, Byrgazov, K, Bock, C, Mannhalter, C, Hörmann, G, Sperr, W R, Lion, T, Zielinski, C C, Valent, P, Zöchbauer-Müller, S
Publicado 2016

Consensus statement for cancer patients requiring intensive care support

por Kiehl, M. G., Beutel, G., Böll, B., Buchheidt, D., Forkert, R., Fuhrmann, V., Knöbl, P., Kochanek, M., Kroschinsky, F., La Rosée, P., Liebregts, T., Lück, C., Olgemoeller, U., Schalk, E., Shimabukuro-Vornhagen, A., Sperr, W. R., Staudinger, T., von Bergwelt Baildon, M., Wohlfarth, P., Zeremski, V., Schellongowski, P.
Publicado 2018

P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

por Reiter, A., Gotlib, J., Álvarez-Twose, I., Radia, D. H., Luebke, J., Bobbili, P. J., Wang, A., Norregaard, C., Dimitrijević, S., Sullivan, E., Louie-Gao, M., Schwaab, J., Galinsky, I. A., Perkins, C., Sperr, W. R., Sriskandarajah, P., Chin, A., Sendhil, S. R., Duh, M. S., Valent, P., DeAngelo, D. J.
Publicado 2022

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE

por Reiter, A., Gotlib, J., Álvarez-Twose, I., Radia, D. H., Luebke, J., Bobbili, P. J., Wang, A., Norregaard, C., Dimitrijević, S., Sullivan, E., Louie-Gao, M., Schwaab, J., Galinsky, I. A., Perkins, C., Sperr, W. R., Sriskandarajah, P., Chin, A., Sendhil, S. R., Duh, M. S., Valent, P., DeAngelo, D. J.
Publicado 2022

P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

por Reiter, A., Gotlib, J., Álvarez-Twose, I., Radia, D. H., Luebke, J., Bobbili, P. J., Wang, A., Norregaard, C., Dimitrijević, S., Sullivan, E., Louie-Gao, M., Schwaab, J., Galinsky, I. A., Perkins, C., Sperr, W. R., Sriskandarajah, P., Chin, A., Sendhil, S. R., Duh, M. S., Valent, P., DeAngelo, D. J.
Publicado 2022

Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study

por Zeilinger, E. L., Oppenauer, C., Knefel, M., Kantor, V., Schneckenreiter, C., Lubowitzki, S., Krammer, K., Popinger, C., Kitta, A., Kum, L., Adamidis, F., Unseld, M., Masel, E. K., Füreder, T., Zöchbauer-Müller, S., Bartsch, R., Raderer, M., Prager, G., Krauth, M. T., Sperr, W. R., Porpaczy, E., Staber, P. B., Valent, P., Gaiger, A.
Publicado 2022